New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia

According to a story from the FH Foundation, the non-profit organization has released a vital consensus statement regarding the diagnosis of familial hypercholesterolemia, which is the most prevalent genetic cause…

Continue Reading New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia
A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment
https://pixabay.com/en/clock-time-watch-hours-minutes-407101/

A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment

According to a story from cbc.ca, Cole Pringle is a 31-year-old man from Regina, Saskatchewan with spinal muscular atrophy, a debilitating illness that severely affects his mobility. He was diagnosed…

Continue Reading A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment
Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease
nuzree / Pixabay

Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease

According to a public release from University of Texas Health Center at San Antonio on eurekalert.org, research using fruit fly tauopathy disease models has revealed a genetic "copy-paste" activity that…

Continue Reading Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease
Could This Mouth Swab Save Lives? Genepath Test Diagnosis Krabbe Disease and Much More
https://pixabay.com/en/baby-child-cute-doll-expression-17366/

Could This Mouth Swab Save Lives? Genepath Test Diagnosis Krabbe Disease and Much More

Ashley Wibberly’s son Levi was born in September of 2013 and lived for just 20 months with Krabbe disease. Ashley couldn’t have seen it coming. Now, however, a new test…

Continue Reading Could This Mouth Swab Save Lives? Genepath Test Diagnosis Krabbe Disease and Much More
October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
mohamed_hassan / Pixabay

October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease

An ongoing Phase 3 clinical trial program is investigating the drug PXT3003 as an experimental treatment for Charcot-Marie-Tooth disease type 1A in adults. Pharnext SA says that they expect to…

Continue Reading October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing
klimkin / Pixabay

For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing

According to a story from the Los Angeles Daily News, for children with debilitating rare illnesses like cerebral palsy, epilepsy, or muscular dystrophy, it can often take a long time…

Continue Reading For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing
A New App has Been Developed to Support the Neuroendocrine Tumour Community
JESHOOTScom / Pixabay

A New App has Been Developed to Support the Neuroendocrine Tumour Community

Novartis has teamed up with Numinous Games to develop Galaxies of Hope, an app that is designed to support the neuroendocrine tumour (NET) community. You can read the original source…

Continue Reading A New App has Been Developed to Support the Neuroendocrine Tumour Community